<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02915276</url>
  </required_header>
  <id_info>
    <org_study_id>blatocentesesJBNKL2016</org_study_id>
    <nct_id>NCT02915276</nct_id>
  </id_info>
  <brief_title>The Effectiveness of Blastocentesis Versus Trophectoderm Biopsy</brief_title>
  <official_title>Comparison of Genomic DNA Analysis Between Blastocoele Fluid and Trophectoderm Biopsy in Human Embryos</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Center for Reproductive an Genetic Health</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Center for Reproductive an Genetic Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      For the purpose of this study, the investigators will perform the removal of trophectoderm
      (TE) the cells as required for the purpose of pre-implantation genetic screening, in order to
      perform the genetic analysis. Additionally, the investigators will remove the blastocoelic
      fluid (BF) and perform additional genetic analysis on the embryo in order to determine the
      agreement of the genetics results between TE cells and BF.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The human embryo (fertilised egg) develops from a single cell and goes through several
      developmental stages in order to prepare for implantation inside the womb. During the fifth
      and sixth day post fertilisation, the embryo becomes a blastocyst. It consists of 100-150
      cells and has two cell types. The inner cell mass (ICM) will give rise to the baby and the
      trophectoderm cells will become the placenta. The trophectoderm (TE) cells surround the ICM.
      Following the formation of the two cell types, the TE cells start producing fluid. The
      progressive accumulation of fluid leads to the formation of a cavity that expands to form the
      blastocele cavity. This cavity contains fluid is known as blastocoelic fluid (BF). The fluid
      can contain proteins, cells and genetic material. Traditionally to make a genetic diagnosis
      or when to screen embryos for abnormal chromosome number, cells are removed (biopsy) from the
      trophectoderm. In experienced hands, this is a very safe procedure and causes minimal damage
      to the embryo. However, recent studies have shown that blastocoele fluid may contain genetic
      material which can be aspirated (drawn out) from the blastocole cavity (blastocentesis) and
      used for genetic analysis of an embryo. This is potentially less invasive and harmful to the
      embryo. The aim of this study is to compare genetic analysis obtained following
      blastocentesis versus trophectoderm cell biopsy.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>October 2016</start_date>
  <completion_date type="Anticipated">May 2017</completion_date>
  <primary_completion_date type="Anticipated">March 2017</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of blastocyst with genomic DNA present in the blastocoelic cavity</measure>
    <time_frame>Twelve months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Abnormal Karyotype</condition>
  <arm_group>
    <arm_group_label>Blastocentisis</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The blastocoelic fluid will be aspirated from the embryonic cavity on day 5 or 6 of development and will be subjected to genetic analysis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Trophectoderm biopsy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Throphectoderm cells will be removed from the embryo on day 5 or 6 of development and will be subjected to genetic analysis</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Blastocentisis</intervention_name>
    <description>Removal of blastocoelic fluid from the blastocoelic cavity</description>
    <arm_group_label>Blastocentisis</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Trophectoderm biopsy</intervention_name>
    <description>Removal of trophectoderm cells from the blastocyst</description>
    <arm_group_label>Trophectoderm biopsy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Couples undergoing assisted reproduction for pre-implantation genetic diagnosis

        Exclusion Criteria:

          -  Any other couples undergoing assisted reproduction
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Paul Serhal, MD, PhD</last_name>
    <phone>02078372905</phone>
    <email>paul.serhal@crgh.co.uk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Kalliopi Loutradi</name>
      <address>
        <city>London</city>
        <zip>W1W 5QS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <results_reference>
    <citation>Magli MC, Pomante A, Cafueri G, Valerio M, Crippa A, Ferraretti AP, Gianaroli L. Preimplantation genetic testing: polar bodies, blastomeres, trophectoderm cells, or blastocoelic fluid? Fertil Steril. 2016 Mar;105(3):676-683.e5. doi: 10.1016/j.fertnstert.2015.11.018. Epub 2015 Dec 1.</citation>
    <PMID>26658131</PMID>
  </results_reference>
  <results_reference>
    <citation>Gianaroli L, Magli MC, Pomante A, Crivello AM, Cafueri G, Valerio M, Ferraretti AP. Blastocentesis: a source of DNA for preimplantation genetic testing. Results from a pilot study. Fertil Steril. 2014 Dec;102(6):1692-9.e6. doi: 10.1016/j.fertnstert.2014.08.021. Epub 2014 Sep 23. Erratum in: Fertil Steril. 2015 Aug;104(2):498.</citation>
    <PMID>25256935</PMID>
  </results_reference>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 22, 2016</study_first_submitted>
  <study_first_submitted_qc>September 23, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 27, 2016</study_first_posted>
  <last_update_submitted>September 23, 2016</last_update_submitted>
  <last_update_submitted_qc>September 23, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 27, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Center for Reproductive an Genetic Health</investigator_affiliation>
    <investigator_full_name>Kalliopi Loutradi</investigator_full_name>
    <investigator_title>Deputy Head of Embryology</investigator_title>
  </responsible_party>
  <keyword>Blastocyst</keyword>
  <keyword>Human</keyword>
  <keyword>DNA</keyword>
  <keyword>Blastocentesis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Abnormal Karyotype</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

